DBI’s Proprietary Technology: TOPS DBS Temporally Optimized Patterned Stimulation (TOPS™) Deep Brain Stimulation (DBS) to improve effectiveness of DBS on motor symptoms of Parkinson’s disease to extend the battery life of DBS systems for less frequent battery changes DBI is conducting a clinical stu
Employees: 1-10
Investors 1
| Date | Name | Website |
| - | NDI Medica... | ndimedical... |
Mentions in press and media 3
| Date | Title | Description |
| 09.06.2022 | Deep Brain Stimulation Systems Market is expected to exceed the value of USD 2,122.8 Million by the end of 2027 | Emergen Research Logo Technological advancements in Deep Brain Stimulation (DBS) Systems, significant prevalence of Parkinson’s disease, dystonia Deep Brain Stimulation Systems Market Size – USD 1,227.5 Million in 2019, DBS Systems Market G... |
| 28.05.2013 | NDI Medical launches spinoff to optimize deep brain stimulation for Parkinson’s disease | DBS devices comprises electrodes, leads and a pulse generator that are implanted in patients. They deliver electrical pulses to targeted areas of the brain to block electrical nerve signals that generate PD symptoms like tremor, stiffness, ... |
| - | NDI Medical launches spinoff to optimize deep brain stimulation for Parkinson’s disease | In the decade since the FDA cleared the first deep brain stimulation device to treat symptoms of Parkinson’s disease (Medtronic’s Activa), it’s become established a safe, effective option along the spectrum of care. But Geoff Thrope, the fo... |